The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. (2004) · Nature · doi:10.1038/nature02371 · Cited by 1,065
Self-citationSp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,049
Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Self-citationKlf4 is a transcription factor required for establishing the barrier function of the skin
Segre, J. A., Bauer, C., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/11926 · Cited by 788
Shields, J. M., Christy, R. J., & Yang, V. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20009 · Cited by 652
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Katz, J. P., Perreault, N., Goldstein, B. G., Lee, C. S., Labosky, P. A., Yang, V. W., & Kaestner, K. H. (2002) · Development · doi:10.1242/dev.129.11.2619 · Cited by 594
Compromised HOXA5 function can limit p53 expression in human breast tumours
Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., Marks, J., & Sukumar, S. (2000) · Nature · doi:10.1038/35016125 · Cited by 482
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.
Zarling, J. M., Shoyab, M., Marquardt, H., Hanson, M. B., Lioubin, M. N., & Todaro, G. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9739 · Cited by 435
Jacobs, J. J. L., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van de Vijver, M. J., Koh, E. Y., Daley, G. Q., et al. (2000) · Nature Genetics · doi:10.1038/81583 · Cited by 368
Absence of WAF1 mutations in a variety of human malignancies
Shiohara, M., el-Deiry, W., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D., Vogelstein, B., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.11.3781.bloodjournal84113781 · Cited by 368
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J. A., & Ewen, M. E. (1997) · Nature · doi:10.1038/386177a0 · Cited by 357
Self-citationZhang, W., Geiman, D. E., Shields, J. M., Dang, D. T., Mahatan, C. S., Kaestner, K. H., Biggs, J. R., Kraft, A. S., & Yang, V. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000062200 · Cited by 327
Garrett-Sinha, L. A., Eberspaecher, H., Seldin, M. F., & de Crombrugghe, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31384 · Cited by 313
Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer
Zhao, W., Hisamuddin, I. M., Nandan, M. O., Babbin, B. A., Lamb, N. E., & Yang, V. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207067 · Cited by 305
Wei, D., Gong, W., Kanai, M., Schlunk, C., Wang, L., Yao, J. C., Wu, T.-T., Huang, S., & Xie, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3619 · Cited by 299
Induction of cyclin D1 overexpression by activated ras.
Filmus, J., Robles, A. I., Shi, W., Wong, M. J. H., Colombo, L. L., & Conti, C. J. (1994) · PubMed · Cited by 295
Chen, X., Johns, D. C., Geiman, D. E., Marban, E., Dang, D. T., Hamlin, G., Sun, R., & Yang, V. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101194200 · Cited by 266
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 255
Self-citationKatz, J. P., Perreault, N., Goldstein, B. G., Actman, L., McNally, S. R., Silberg, D. G., Furth, E. E., & Kaestner, K. H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.022 · Cited by 246
Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster, K. W., Frost, A. R., McKie-Bell, P., Lin, C., Engler, J. A., Grizzle, W. E., & Ruppert, J. M. (2000) · PubMed · Cited by 244
Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect
Li, C.-Y., Suardet, L., & Little, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.4971 · Cited by 239
Transcriptional Activation of the p21 Gene by Interleukin-6 Type Cytokines
Bellido, T., O'Brien, C. A., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21137 · Cited by 224
Chen, X., Whitney, E. M., Gao, S. Y., & Yang, V. W. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01449-3 · Cited by 215
Luo, A., Kong, J., Hu, G., Liew, C.-C., Xiong, M., Wang, X., Ji, J., Wang, T., Zhi, H., Wu, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207218 · Cited by 199
Foster, K. W., Liu, Z., Nail, C. D., Li, X., Fitzgerald, T. J., Bailey, S. K., Frost, A. R., Louro, I. D., Townes, T. M., Paterson, A. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208307 · Cited by 196
Foster, K. W., Ren, S., Louro, I. D., Lobo-Ruppert, S. M., McKie-Bell, P., Grizzle, W. E., Hayes, M., Broker, T. R., Chow, L. T., & Ruppert, J. M. (1999) · PubMed · Cited by 187
Dang, D. T., Chen, X., Feng, J., Torbenson, M., Dang, L. H., & Yang, V. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206413 · Cited by 168
Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L. J., Bast, R. C., Iglehart, J. D., & Marks, J. R. (1994) · PubMed · Cited by 147
Dang, D. T., Mahatan, C. S., Dang, L. H., Agboola, I. A., & Yang, V. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204645 · Cited by 127
Geiman, D. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1106 · Cited by 127
Rowland, B. D., Denissov, S. G., Douma, S., Stunnenberg, H. G., Bernards, R., & Peeper, D. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00085-5 · Cited by 120
Self-citationJaubert, J., Cheng, J., & Segre, J. A. (2003) · Development · doi:10.1242/dev.00477 · Cited by 114
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence
Peeper, D. S., Shvarts, A., Brummelkamp, T. R., Douma, S., Koh, E. Y., Daley, G. Q., & Bernards, R. (2002) · Nature Cell Biology · doi:10.1038/ncb742 · Cited by 111
Self-citationTon-That, H., Kaestner, K. H., Shields, J. M., Mahatanankoon, C. S., & Yang, V. W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01465-8 · Cited by 108
Escape from premature senescence is not sufficient for oncogenic transformation by Ras
Peeper, D. S., Dannenberg, J., Douma, S., Riele, H. T., & Bernards, R. (2001) · Nature Cell Biology · doi:10.1038/35055110 · Cited by 105
Self-citationDang, D. T., Bachman, K. E., Mahatan, C. S., Dang, L. H., Giardiello, F. M., & Yang, V. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01727-0 · Cited by 100
Jenkins, T. D., Opitz, O. G., Okano, J., & Rustgi, A. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10747 · Cited by 84
Research works printed but not linked: 3
- Ohnishi, S. et al. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 308, 251–256 (2003). · doi:10.1016/s0006-291x(03)01356-1
- Shie, J. L. et al. Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G806–G814 (2000). · doi:10.1152/ajpgi.2000.279.4.g806
- Li, C. et al. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Oncogene 20, 8193–8202 (2001). · doi:10.1038/sj.onc.1205046
Cited by
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
“For example, function-based genomewide screens have unraveled unanticipated tumorigenic mechanisms (Peeper et al., 2002; Berns et al., 2004; Rowland et al., 2005).”
BackgroundMethodSelf-citationChemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Metadata
- Authors
- Rowland, B. D., Bernards, R., & Peeper, D. S.
- Venue
- Nature Cell Biology
- Published
- 2005-10-23
- Volume
- 7
- Issue
- 11
- Pages
- 1074-1082
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2156935469
- Cited by
- 590
- References
- 47
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.